The analyses by tumor grade also highlighted the unique observation that patients with low-grade AA and normal CEA levels had a particularly good prognosis (99% survival at 5 years and 94% survival at 5 years in metastatic disease). The gene discussed is CEACAM5; the disease is neoplasm.